Miscellaneous iron-related disorders

Iron Physiology and Pathophysiology in Humans

Volumn , Issue , 2012, Pages 417-439

  Beaumont, Carole ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Cataract; Ceruloplasmin; Ferritin; Genetic diseases; Iron; Transferrin

Indexed keywords

EID: 84897467091     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-485-2_21     Document Type: Chapter

References (150)

1. Bonneau D, Winter-Fuseau I, Loiseau MN, et al. Bilateral cataract and high serum ferritin: a new dominant genetic disorder? J Med Genet. 1995;32:778-9.
2. Girelli D, Olivieri O, De Franceschi L, Corrocher R, Bergamaschi G, Cazzola M. A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol. 1995;90:931-4.
3. Beaumont C, Leneuve P, Devaux I, et al. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet. 1995;11:444-6.
4. Girelli D, Corrocher R, Bisceglia L, et al. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood. 1995;86:4050-3.
5. Millonig G, Muckenthaler MU, Mueller S. Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder. Hum Genomics. 2010;4:250-62.
6. Henderson BR, Menotti E, Bonnard C, Kuhn LC. Optimal sequence and structure of iron-responsive elements. Selection of RNA stem-loops with high affinity for iron regulatory factor. J Biol Chem. 1994;269:17481-9.
7. Sierzputowska-Gracz H, McKenzie RA, Theil EC. The importance of a single G in the hairpin loop of the iron responsive element (IRE) in ferritin mRNA for structure: an NMR spectroscopy study. Nucleic Acids Res. 1995;23:146-53.
8. Theil EC. Iron regulatory elements (IREs): a family of mRNA non-coding sequences. Biochem J. 1994;304:1-11.
9. Ke Y, Wu J, Leibold EA, Walden WE, Theil EC. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation? J Biol Chem. 1998;273:23637-40.
10. Burdon KP, Sharma S, Chen CS, Dimasi DP, Mackey DA, Craig JE. A novel deletion in the FTL gene causes hereditary hyperferritinemia cataract syndrome (HHCS) by alteration of the transcription start site. Hum Mutat. 2007;28:742.
11. Arosio C, Fossati L, Vigano M, Trombini P, Cazzaniga G, Piperno A. Hereditary hyperferritinemia cataract syndrome: a de novo mutation in the iron responsive element of the L-ferritin gene. Haematologica. 1999;84:560-1.
12. Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood. 2003;102:1904-10.
13. McLeod JL, Craig J, Gumley S, Roberts S, Kirkland MA. Mutation spectrum in Australian pedigrees with hereditary hyperferritinaemia-cataract syndrome reveals novel and de novo mutations. Br J Haematol. 2002;118:1179-82.
14. Paraskeva E, Gray NK, Schlager B, Wehr K, Hentze MW. Ribosomal pausing and scanning arrest as mechanisms of translational regulation from cap-distal iron-responsive elements. Mol Cell Biol. 1999;19:807-16.
15. Zahringer J, Baliga BS, Munro HN. Novel mechanism for translational control in regulation of ferritin synthesis by iron. Proc Natl Acad Sci USA. 1976;73:857-61.
16. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA. 1996;93:8175-82.
17. Cazzola M, Skoda RC. Translational pathophysiology: a novel molecular mechanism of human disease. Blood. 2000;95:3280-8.
18. Levi S, Girelli D, Perrone F, et al. Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood. 1998;91:4180-7.
19. Allerson CR, Cazzola M, Rouault TA. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J Biol Chem. 1999;274:26439-47.
20. Martin ME, Fargion S, Brissot P, Pellat B, Beaumont C. A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome. Blood. 1998;91:319-23.
21. Jaffrey SR, Haile DJ, Klausner RD, Harford JB. The interaction between the iron-responsive element binding protein and its cognate RNA is highly dependent upon both RNA sequence and structure. Nucleic Acids Res. 1993;21:4627-31.
22. Leibold EA, Laudano A, Yu Y. Structural requirements of iron-responsive elements for binding of the protein involved in both transferrin receptor and ferritin mRNA post-transcriptional regulation. Nucleic Acids Res. 1990;18:1819-24.
23. Worwood M, Cragg SJ, Wagstaff M, Jacobs A. Binding of human serum ferritin to concanavalin A. Clin Sci (Lond). 1979;56:83-7.
24. Worwood M, Dawkins S, Wagstaff M, Jacobs A. The purification and properties of ferritin from human serum. Biochem J. 1976;157:97-103.
25. Ghosh S, Hevi S, Chuck SL. Regulated secretion of glycosylated human ferritin from hepatocytes. Blood. 2004;103:2369-76.
26. Worwood M. Serum ferritin. Clin Sci (Lond). 1986;70:215-20.
27. Aguilar-Martinez P, Schved JF, Brissot P. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities. Am J Gastroenterol. 2005;100:1185-94.
28. Girelli D, Corrocher R, Bisceglia L, et al. Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene. Blood. 1997;90:2084-8.
29. Girelli D, Bozzini C, Zecchina G, et al. Clinical, biochemical and molecular findings in a series of families with hereditary hyperferritinaemia-cataract syndrome. Br J Haematol. 2001;115:334-40.
30. Chang-Godinich A, Ades S, Schenkein D, Brooks D, Stambolian D, Raizman MB. Lens changes in hereditary hyperferritinemia-cataract syndrome. Am J Ophthalmol. 2001;132:786-8.
31. Craig JE, Clark JB, McLeod JL, et al. Hereditary hyperferritinemia-cataract syndrome: prevalence, lens morphology, spectrum of mutations, and clinical presentations. Arch Ophthalmol. 2003;121:1753-61.
32. Feys J, Nodarian M, Aygalenq P, Cattan D, Bouccara AS, Beaumont C. Hereditary hyperferritinemia syndrome and cataract. J Fr Ophtalmol. 2001;24:847-50.
33. Brooks DG, Manova-Todorova K, Farmer J, et al. Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome. Invest Ophthalmol Vis Sci. 2002;43:1121-6.
34. Cremonesi L, Fumagalli A, Soriani N, et al. Double-gradient denaturing gradient gel electrophoresis assay for identification of L-ferritin iron-responsive element mutations responsible for hereditary hyperferritinemia-cataract syndrome: identification of the new mutation C14G. Clin Chem. 2001;47:491-7.
35. Cremonesi L, Paroni R, Foglieni B, et al. Scanning mutations of the 5 UTR regulatory sequence of L-ferritin by denaturing high-performance liquid chromatography: identification of new mutations. Br J Haematol. 2003;121:173-9.
36. Giansily M, Beaumont C, Desveaux C, Hetet G, Schved JF, Aguilar-Martinez P. Denaturing gradient gel electrophoresis screening for mutations in the hereditary hyperferritinaemia cataract syndrome. Br J Haematol. 2001;112:51-4.
37. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis. 2004;32:131-8.
38. De Domenico I, Ward DM, Musci G, Kaplan J. Iron overload due to mutations in ferroportin. Haematologica. 2006;91:92-5.
39. Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia. Best Pract Res Clin Haematol. 2005;18:251-63.
40. Pietrangelo A, Corradini E, Ferrara F, et al. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Mol Dis. 2006;37:192-6.
41. Kannengiesser C, Jouanolle AM, Hetet G, et al. A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload. Haematologica. 2009;94:335-9.
42. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439-58.
43. de Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet. 2007;44:673-88.
44. Patel BN, Dunn RJ, David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem. 2000;275:4305-10.
45. Anderson GJ, Frazer DM, McKie AT, Vulpe CD. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol Dis. 2002;29:367-75.
46. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21:195-9.
47. De Domenico I, Ward DM, di Patti MC, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823-31.
48. Jeong SY, David S. Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmindeficient mice. J Neurosci. 2006;26:9810-9.
49. Gitlin JD, Schroeder JJ, Lee-Ambrose LM, Cousins RJ. Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem J. 1992;282:835-9.
50. Roeser HP, Lee GR, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest. 1970;49:2408-17.
51. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 1987;37:761-7.
52. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA. 1995;92:2539-43.
53. McNeill A, Pandolfo M, Kuhn J, Shang H, Miyajima H. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol. 2008;60:200-5.
54. He X, Hahn P, Iacovelli J, et al. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 2007;26:649-73.
55. Perez-Aguilar F, Burguera JA, Benlloch S, Berenguer M, Rayon JM. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis. J Hepatol. 2005;42:947-9.
56. Beaumont C, Canonne-Hergaux F. Erythrophagocytosis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin. Transfus Clin Biol. 2005;12:123-30.
57. Origa R, Galanello R, Ganz T, et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007;92:583-8.
58. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood. 2005;105:4103-5.
59. Anderson GJ, Frazer DM. Recent advances in intestinal iron transport. Curr Gastroenterol Rep. 2005;7: 365-72.
60. Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res. 2006;39:15-23.
61. Miyajima H, Takahashi Y, Serizawa M, Kaneko E, Gitlin JD. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic Biol Med. 1996;20:757-60.
62. Miyajima H, Takahashi Y, Kono S, et al. Glucose and oxygen hypometabolism in aceruloplasminemia brains. Intern Med. 2002;41:186-90.
63. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals. 2003;16:205-13.
64. Kono S, Suzuki H, Oda T, et al. Cys-881 is essential for the trafficking and secretion of truncated mutant ceruloplasmin in aceruloplasminemia. J Hepatol. 2007;47:844-50.
65. Bento I, Peixoto C, Zaitsev VN, Lindley PF. Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites. Acta Crystallogr D Biol Crystallogr. 2007;63:240-8.
66. Hellman NE, Kono S, Mancini GM, Hoogeboom AJ, De Jong GJ, Gitlin JD. Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem. 2002;277:46632-8.
67. Kono S, Suzuki H, Takahashi K, et al. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia. Gastroenterology. 2006;131:240-5.
68. Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol. 2007;13:4755-60.
69. Loreal O, Turlin B, Pigeon C, et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol. 2002;36:851-6.
70. Fasano A, Colosimo C, Miyajima H, Tonali PA, Re TJ, Bentivoglio AR. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability. Mov Disord. 2008;23:751-5.
71. Daimon M, Susa S, Ohizumi T, et al. A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J Exp Med. 2000;191:119-25.
72. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol. 1997;41:404-7.
73. Hochstrasser H, Bauer P, Walter U, et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912-7.
74. Mariani R, Arosio C, Pelucchi S, et al. Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation. Gut. 2004;53:756-8.
75. Boddaert N, Le Quan Sang KH, Rotig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood. 2007;110:401-8.
76. Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci. 2004;1012:299-305.
77. Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. Brain Dev. 2007;29:450-3.
78. Yonekawa M, Okabe T, Asamoto Y, Ohta M. A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma. Eur Neurol. 1999;42:157-62.
79. Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA. 1999;96:10812-7.
80. Cherukuri S, Potla R, Sarkar J, Nurko S, Harris ZL, Fox PL. Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab. 2005;2:309-19.
81. Gouya L, Muzeau F, Robreau AM, et al. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene. Gastroenterology. 2007;132:679-86.
82. Hahn P, Qian Y, Dentchev T, et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA. 2004;101:13850-5.
83. Heilmeyer L, Keller W, Vivell O, et al. Congenital atransferrinemia in a 7-year-old girl. Dtsch Med Wochenschr. 1961;86:1745-51.
84. Yefimova MG, Jeanny JC, Guillonneau X, et al. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest Ophthalmol Vis Sci. 2000;41:2343-51.
85. Bloch B, Popovici T, Levin MJ, Tuil D, Kahn A. Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci USA. 1985;82:6706-10.
86. Ponka P, Schulman HM. Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J Biol Chem. 1985;260:14717-21.
87. Kearney SL, Nemeth E, Neufeld EJ, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer. 2007;48:57-63.
88. Trombini P, Coliva T, Nemeth E, et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica. 2007;92:1407-10.
89. Hayashi A, Wada Y, Suzuki T, Shimizu A. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. Am J Hum Genet. 1993;53:201-13.
90. Beutler E, Gelbart T, Lee P, Trevino R, Fernandez MA, Fairbanks VF. Molecular characterization of a case of atransferrinemia. Blood. 2000;96:4071-4.
91. Heilmeyer L, Keller W, Vivell O, Betke K, Woehler F, Keiderling W. Congenital atransferrinemia. Schweiz Med Wochenschr. 1961;91:1203.
92. Asada-Senju M, Maeda T, Sakata T, Hayashi A, Suzuki T. Molecular analysis of the transferrin gene in a patient with hereditary hypotransferrinemia. J Hum Genet. 2002;47:355-9.
93. Knisely AS, Gelbart T, Beutler E. Molecular characterization of a third case of human atransferrinemia. Blood. 2004;104:2607.
94. Aslan D, Crain K, Beutler E. A new case of human atransferrinemia with a previously undescribed mutation in the transferrin gene. Acta Haematol. 2007;118:244-7.
95. Goldwurm S, Casati C, Venturi N, et al. Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J. 2000;1:390-8.
96. Van Rensburg SJ, Carstens ME, Potocnik FC, van der Spuy G, van der Walt BJ, Taljaard JJ. Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? Med Hypotheses. 1995;44:268-72.
97. Zambenedetti P, De Bellis G, Biunno I, Musicco M, Zatta P. Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. J Alzheimers Dis. 2003;5:423-7.
98. Lee PL, Halloran C, Trevino R, Felitti V, Beutler E. Human transferrin G277S mutation: a risk factor for iron deficiency anaemia. Br J Haematol. 2001;115:329-33.
99. Delanghe J, Verstraelen H, Pynaert I, et al. Human transferrin G277S mutation and iron deficiency in pregnancy. Br J Haematol. 2006;132:249-50.
100. Westerhausen M, Meuret G. Transferrin-immune complex disease. Acta Haematol. 1977;57:96-101.
101. Alyanakian MA, Taes Y, Bensaid M, et al. Monoclonal immunoglobulin with antitransferrin activity: a rare cause of hypersideremia with increased transferrin saturation. Blood. 2007;109:359-61.
102. Trenor III CC, Campagna DR, Sellers VM, Andrews NC, Fleming MD. The molecular defect in hypotransferrinemic mice. Blood. 2000;96:1113-8.
103. Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci USA. 1987;84:3457-61.
104. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-81.
105. Cazzola M, Bergamaschi G, Tonon L, et al. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood. 1997;90:814-21.
106. Bosio S, Campanella A, Gramaglia E, et al. C29G in the iron-responsive element of L-ferritin: a new mutation associated with hyperferritinemia-cataract. Blood Cells Mol Dis. 2004;33:31-4.
107. Lachlan KL, Temple IK, Mumford AD. Clinical features and molecular analysis of seven British kindreds with hereditary hyperferritinaemia cataract syndrome. Eur J Hum Genet. 2004;12:790-6.
108. Sanders SJ, Suri M, Ross I. Hereditary hyperferritinaemia-cataract syndrome and differential diagnosis of hereditary haemochromatosis. Postgrad Med J. 2003;79:600-1.
109. Wong K, Barbin Y, Chakrabarti S, Adams P. A point mutation in the iron-responsive element of the L-ferritin in a family with hereditary hyperferritinemia cataract syndrome. Can J Gastroenterol. 2005;19:253-5.
110. Vanita V, Hejtmancik JF, Hennies HC, et al. Sutural cataract associated with a mutation in the ferritin light chain gene (FTL) in a family of Indian origin. Mol Vis. 2006;12:93-9.
111. van der Klooster JM. Hereditary hyperferritinaemia-cataract syndrome. Ned Tijdschr Geneeskd. 2003;147:1923-8.
112. Cicilano M, Zecchina G, Roetto A, et al. Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome. Haematologica. 1999;84:489-92.
113. Ismail AR, Lachlan KL, Mumford AD, Temple IK, Hodgkins PR. Hereditary hyperferritinemia cataract syndrome: ocular, genetic, and biochemical findings. Eur J Ophthalmol. 2006;16:153-60.
114. Simsek S, Nanayakkara PW, Keek JM, Faber LM, Bruin KF, Pals G. Two Dutch families with hereditary hyperferritinaemia-cataract syndrome and heterozygosity for an HFE-related haemochromatosis gene mutation. Neth J Med. 2003;61:291-5.
115. Campagnoli MF, Pimazzoni R, Bosio S, et al. Onset of cataract in early infancy associated with a 32G C transition in the iron responsive element of L-ferritin. Eur J Pediatr. 2002;161:499-502.
116. Garcia-Erce JA, Salvador Osuna C. Genetics of iron overloads and hereditary hyperferritinemia cataract syndrome. An Med Interna. 2003;20:213-4.
117. Ladero JM, Balas A, Garcia-Sanchez F, Vicario JL, Diaz-Rubio M. Hereditary hyperferritinemia-cataract syndrome. Study of a new family in Spain. Rev Esp Enferm Dig. 2004;96:507-11.
118. Balas A, Aviles MJ, Garcia-Sanchez F, Vicario JL. Description of a new mutation in the L-ferrin iron-responsive element associated with hereditary hyperferritinemia-cataract syndrome in a Spanish family. Blood. 1999;93:4020-1.
119. Cervera Bravo A, Sebastian Planas M, Alarabe Alarabe A, Diez Saenz A, Aviles Egea MJ, Balas Perez A. Isolated hyperferritinemia in a healthy male infant: hereditary hyperferritinemia-cataract syndrome. An Esp Pediatr. 2000;52:267-70.
120. Mumford AD, Vulliamy T, Lindsay J, Watson A. Hereditary hyperferritinemia-cataract syndrome: two novel mutations in the L-ferritin iron-responsive element. Blood. 1998;91:367-8.
121. Cremonesi L, Foglieni B, Fermo I, et al. Identification of two novel mutations in the 5' -untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. Haematologica. 2003;88: 1110-6.
122. Garcia-Erce JA, Salvador-Osuna C, Cortes T, Perez-Lungmus G. Congenital cataract syndrome and hyperferritinemia. Med Clin (Barc). 1999;112:398.
123. Ferrante M, Geubel AP, Fevery J, Marogy G, Horsmans Y, Nevens F. Hereditary hyperferritinaemia-cataract syndrome: a challenging diagnosis for the hepatogastroenterologist. Eur J Gastroenterol Hepatol. 2005;17:1247-53.
124. Papanikolaou G, Chandrinou H, Bouzas E, et al. Hereditary hyperferritinemia cataract syndrome in three unrelated families of western Greek origin caused by the C39>G mutation of L-ferritin IRE. Blood Cells Mol Dis. 2006;36:33-40.
125. Garderet L, Hermelin B, Gorin NC, Rosmorduc O. Hereditary hyperferritinemia-cataract syndrome: a novel mutation in the iron-responsive element of the L-ferritin gene in a French family. Am J Med. 2004;117:138-9.
126. Del Castillo Rueda A, Fernandez Ruano ML. Hereditary hyperferritinemia cataracts syndrome in a Spanish family caused by the A40G mutation (Paris) in the L-ferritin (FTL) gene associated with the mutation H63D in the HFE gene. Med Clin (Barc). 2007;129:414-7.
127. Perez de Nanclares G, Castano L, Martul P, et al. Molecular analysis of hereditary hyperferritinemia-cataract syndrome in a large Basque family. J Pediatr Endocrinol Metab. 2001;14:295-300.
128. Aguilar-Martinez P, Biron C, Masmejean C, Jeanjean P, Schved JF. A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome. Blood. 1996;88:1895.
129. Hughes M, Vosylius P. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis. Clin Lab Haematol. 2006;28:357-9.
130. Barton JC, Beutler E, Gelbart T. Coinheritance of alleles associated with hemochromatosis and hereditary hyperferritinemia-cataract syndrome. Blood. 1998;92:4480.
131. Phillips JD, Warby CA, Kushner JP. Identification of a novel mutation in the L-ferritin IRE leading to hereditary hyperferritinemia-cataract syndrome. Am J Med Genet A. 2005;134A:77-9.
132. Camaschella C, Zecchina G, Lockitch G, et al. A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. Br J Haematol. 2000;108:480-2.
133. Girelli D, Piccoli P, Corrocher R. "Hyperferritinemia-cataract syndrome." Description of a new hereditary disease, from anamnesis to molecular diagnosis. Minerva Med. 1997;88:405-10.
134. Cazzola M, Foglieni B, Bergamaschi G, Levi S, Lazzarino M, Arosio P. A novel deletion of the L-ferritin ironresponsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome. Br J Haematol. 2002;116:667-70.
135. Okamoto N, Wada S, Oga T, et al. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet. 1996;97:755-8.
136. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 1998;67:972S-7.
137. Nagata M, Takiyama Y, Shimazaki H, Nakano I, Miyajima H. A case of aceruloplasminemia presenting as cerebellar ataxia with homozygous mutation nt2602 delG. No To Shinkei. 2004;56:885-9.
138. Bosio S, De Gobbi M, Roetto A, et al. Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood. 2002;100:2246-8.
139. Daimon M, Kato T, Kawanami T, et al. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem Biophys Res Commun. 1995;217:89-95.
140. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet. 1996;5:81-4.
141. Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology. 2001;57:2205-10.
142. Takeuchi Y, Yoshikawa M, Tsujino T, et al. A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J Neurol Neurosurg Psychiatry. 2002;72:543-5.
143. Hofmann WP, Welsch C, Takahashi Y, et al. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia. Scand J Gastroenterol. 2007;42:1088-94.
144. Hellman NE, Kono S, Miyajima H, Gitlin JD. Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem. 2002;277:1375-80.
145. Shang HF, Jiang XF, Burgunder JM, Chen Q, Zhou D. Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus. Mov Disord. 2006;21:2217-20.
146. Yomono H, Kurisaki H, Murayama S, Hebisawa A, Miyajima H, Takahashi Y. An autopsy case of multiple system atrophy with a heteroallelic ceruloplasmin gene mutation. Rinsho Shinkeigaku. 2003;43:398-402.
147. Di Raimondo D, Pinto A, Tuttolomondo A, Fernandez P, Camaschella C, Licata G. Aceruloplasminemia: a case report. Intern Emerg Med. 2008;3:395-9.
148. Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med. 2003;42:599-604.
149. Yazaki M, Yoshida K, Nakamura A, et al. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J Neurol Sci. 1998;156:30-4.
150. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet. 1995;9:267-72.